Detection of Rheumatoid Arthritis–Interstitial Lung Disease Is Enhanced by Serum Biomarkers

Tracy J. Doyle(Brigham and Women's Hospital), Iván O. Rosas(Brigham and Women's Hospital), Gary M. Hunninghake(Brigham and Women's Hospital), Diane Koontz(Center for Rheumatology), Augustine M.K. Choi(Cornell University), Michael E. Weinblatt(Brigham and Women's Hospital), Souheil El‐Chemaly(AVEO Oncology (United States)), María F. Golzarri(Brigham and Women's Hospital), George R. Washko(Laboratory Imaging (Czechia)), Hiroto Hatabu(Harvard University), Michelle Frits(ENT and Allergy), Andrés Traslosheros(Brigham and Women's Hospital), Mizuki Nishino(Brigham and Women's Hospital), Paul F. Dellaripa(Brigham and Women's Hospital), Chester V. Oddis(University of Pittsburgh), Juan C. Osorio(Laboratory of Molecular Genetics), Nancy A. Shadick(Brigham and Women's Hospital), Guodong Wu(Lovelace Respiratory Research Institute), Sarah Chu(Brigham and Women's Hospital), Carl R. Fuhrman(University of Pittsburgh), Dana P. Ascherman(University of Pittsburgh), Christine Iannaccone(ENT and Allergy), Avignat S. Patel(Harvard University)
American Journal of Respiratory and Critical Care Medicine
March 31, 2015
Cited by 216


Related Papers